GTP cyclohydrolase regulation: implications for brain development and function

Area of Science:

• Biochemistry
• Neuroscience
• Genetics

Background:

• Tetrahydrobiopterin (BH4) is an essential cofactor for synthesizing dopamine, noradrenaline, and serotonin.
• GTP cyclohydrolase (GCH) is the rate-limiting enzyme in BH4 biosynthesis.
• Genetic defects in GCH can cause dopa-responsive dystonia due to partial BH4 deficiency.

Purpose of the Study:

• To investigate the transcriptional control of the GCH gene.
• To explore the role of BH4 in dopaminergic development and motor function.

Main Methods:

• Analyzed GCH gene expression in RAW264 cells stimulated with bacterial lipopolysaccharide (LPS).
• Investigated the effects of MEK1/2 and NF-κB pathway inhibitors on LPS-induced GCH expression.
• Studied motor disorders and neurotransmitter levels in biopterin-deficient transgenic mice.

Main Results:

• LPS significantly enhanced GCH expression in RAW264 cells, an effect suppressed by MEK1/2 and NF-κB inhibitors.
• Biopterin-deficient mice exhibited motor disorders.
• Dopamine and tyrosine hydroxylase (TH) protein levels were markedly increased in wild-type mice from birth to P21 but abolished in biopterin-deficient mice.

Conclusions:

• The NF-κB and MEK1/2 signaling pathways are involved in regulating GCH gene expression.
• Developmental psychomotor symptoms in BH4 deficiency are partly due to the dependence of dopaminergic development on BH4 availability.
• BH4 is critical for normal dopaminergic development and motor function.